Cargando…
Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy
BACKGROUND: Proteomics may help us better understand the changes of multiple proteins involved in oncogenesis and progression of prostate cancer(PCa) and identify more diagnostic and prognostic biomarkers. The aim of this study was to screen biomarkers of PCa by the proteomics analysis using isobari...
Autores principales: | Sun, Chuanyu, Song, Chao, Ma, Zhicheng, Xu, Ke, Zhang, Yang, Jin, Hong, Tong, Shijun, Ding, Weihong, Xia, Guowei, Ding, Qiang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100237/ https://www.ncbi.nlm.nih.gov/pubmed/21504578 http://dx.doi.org/10.1186/1477-5956-9-22 |
Ejemplares similares
-
Periostin: a promising target of therapeutical intervention for prostate cancer
por: Sun, Chuanyu, et al.
Publicado: (2011) -
iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis
por: Ikeda, Daiki, et al.
Publicado: (2013) -
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
por: Swiatly, Agata, et al.
Publicado: (2018) -
Identification of Urinary Biomarkers for Exercise-Induced Immunosuppression by iTRAQ Proteomics
por: Xu, Guoqin, et al.
Publicado: (2020) -
Preliminary quantitative proteomics analysis in chronic and latent Keshan disease by iTRAQ labeling approach
por: Sun, Yuxiao, et al.
Publicado: (2017)